May 15, 2020
The Federal Circuit will continue to hold remote oral arguments into the summer, Gilead is allowing some generic-drug makers to produce versions of its antiviral treatment remdesivir, and companies that are allegedly upcharging for coronavirus-related products are continuing to find themselves in court for trademark law violations.
May 11, 2020
The Federal Circuit on Monday upheld a Patent Trial and Appeal Board decision that ESET LLC failed to prove that a Finjan computer antivirus patent is invalid, dismissing ESET's argument that it faced "undeserved prejudice" from the board, a claim Finjan called "simply nonsense."